BioSpace News Archive

BioCapital

Who’s on Top: The Current Leaders in Biopharma Diversity

For BioSpace’s recent Ideal Employer report, life sciences professionals weighed in on the topic.

November 4, 2019
·
3 min read
·
Kymberlie Krieger
Business

Are Diversity and Inclusion Part of Your Organization’s Culture?

In the United States, an organization’s culture has been at the forefront of talent attraction and employee engagement initiatives for more than a decade.

November 4, 2019
·
4 min read
·
By Dana Dunbar SHRM-SCP
Pharm Country

New 3D Bioprinting Technique Utilizes Vasculature that Closely Simulates Human Skin

Researchers at Rensselaer Polytechnic Institute developed a technique for 3D printing living skin that also has blood vessels.

November 4, 2019
·
2 min read
·
Mark Terry
Tecentriq Continues Upward Projection by Proving Efficacy Over and Over

The versatile drug currently treats locally advanced or metastatic urothelial carcinoma, metastatic non-small cell lung cancer, metastatic triple-negative breast cancer, and extensive-stage small cell lung cancer.

November 4, 2019
·
3 min read
·
Elizabeth Glasure
Policy

ORYX Provides Strategic Update on the Clinical Development of Oncolytic Virotherapy ParvOryx

Endorsement of pivotal development program in recurrent glioblastoma (rGBM) from both EMA and FDA

November 4, 2019
·
4 min read
Business

White House Nominates MD Anderson’s Stephen Hahn as Next FDA Commissioner

Late Friday, President Donald Trump put forth Hahn’s name to take over the top spot of the nation’s regulatory agency.

November 4, 2019
·
2 min read
·
Alex Keown
ADC Therapeutics Announces Publication of ADCT-402 Data in Clinical Cancer Research

Data support potential of ADCT-402 to become an important treatment option for patients with relapsed or refractory diffuse large B-cell lymphoma

November 4, 2019
·
5 min read
Recipharm launches Recipharm Analytical Solutions™ as its stand-alone offering for analytical chemistry

Recipharm, the contract development and manufacturing organisation, has launched Recipharm Analytical Solutions™, a stand-alone service to support pharmaceutical companies with their Quality Control and analytical requirements.

November 4, 2019
·
3 min read
Policy

AVEO Stunned As FDA Suggests Another Delay in Filing NDA for RCC Drug

AVEO said it received preliminary feedback from the FDA and the regulatory agency recommended not filing the NDA at this time based on its assessment of the totality of evidence in the Phase III trial.

November 4, 2019
·
2 min read
·
Alex Keown
Deals

Amryt Pharma PLC: Notice of Trading Update

Amryt, a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases, will announce a trading update for the nine-months ended 30 September 2019 on Tuesday, 5 November 2019.

November 4, 2019
·
3 min read